Señales en vivo de RVLP | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (20 oct 2023 @ 16:00):

Stats
Volumen de hoy	63.96M
Volumen promedio	24.42M
Capitalización de mercado	3.14M
EPS	$0 ( 2024-03-18 )
Próxima fecha de ganancias	( $0 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0397
ATR14	$0.0230 (500.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-10-19	Harsaul Foundation	Sell	9 363 760	Ordinary Shares
2023-10-20	Harsaul Foundation	Sell	4 758 899	Ordinary Shares
2023-10-19	Altchem Ltd	Sell	9 363 760	Ordinary Shares
2023-10-20	Altchem Ltd	Sell	4 758 899	Ordinary Shares
2023-10-18	Harsaul Foundation	Sell	3 421 537	Ordinary Shares

INSIDER POWER
-78.90
Last 95 transactions
Buy: 43 304 967 \| Sell: 77 056 281

Volumen Correlación

Largo: -0.31 (neutral)

Corto: -0.42 (neutral)

Signal:(32.959) Neutral

RVL Pharmaceuticals plc Correlación

10 Correlaciones Más Positivas
CSSEP	0.969
KBNT	0.967
AGFY	0.965
IDBA	0.96
CSSEN	0.959
IRBT	0.956
HGEN	0.953
GOVX	0.947
SINT	0.945
REVB	0.945

10 Correlaciones Más Negativas
ATVI	-0.958
AMYT	-0.956
DVCR	-0.954
TIOAU	-0.953
AVEO	-0.95
NVCN	-0.95
FLXS	-0.949
INBK	-0.948
APXI	-0.947
STAY	-0.943

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

RVL Pharmaceuticals plc Correlación - Moneda/Commodity

-0.36
( neutral )

0.19
( neutral )

0.00
( neutral )

0.26
( neutral )

0.75
( moderate )

-0.88
( strong negative )

RVL Pharmaceuticals plc Finanzas

Annual	2022
Ingresos:	$49.72M
Beneficio Bruto:	$40.27M (80.98 %)
EPS:	$-0.580

FY	2022
Ingresos:	$49.72M
Beneficio Bruto:	$40.27M (80.98 %)
EPS:	$-0.580

FY	2021
Ingresos:	$17.50M
Beneficio Bruto:	$13.88M (79.33 %)
EPS:	$-0.960

FY	2020
Ingresos:	$177.88M
Beneficio Bruto:	$103.40M (58.13 %)
EPS:	$-1.310

Financial Reports:

No articles found.

RVL Pharmaceuticals plc

RVL Pharmaceuticals plc, a specialty pharmaceutical company, focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas in the United States, Argentina, and Hungary. The company is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.

Actualizaciones en tiempo real para RVL Pharmaceuticals plc [RVLP]

Upcoming Earnings Alert